Patient: Page 22
-
PharmaVoice Team/PharmaVoice
Fun Facts About the PharmaVOICE 100
Where they were born? The PharmaVOICE 100 may come from all over, but what they have in common is a sincere desire to improve the lives of patients everywhere. What was their first job? We thought it would be fun to know how these highly successful executives earned their first paychecks. As it t...
By PharmaVoice Team • Aug. 1, 2015 -
PharmaVoice Team/PharmaVoice
Overcoming the Challenges that Hinder Innovation
PharmaVOICE 100 honorees discuss the challenges that the industry needs to overcome to support future innovation. Between 2009 and 2014, the annual growth rate for the top 25 life-sciences companies slowed from the prior decade’s double-digit average to only 1% annually, according to a recent rep...
By PharmaVoice Team • Aug. 1, 2015 -
Explore the Trendline➔
Stock via Getty Images
TrendlineClinical trial diversity
As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Innovation In a Patient-Centric World
From healthcare reform to the push for value in medicines to personalized healthcare, the patient is now at the center of, well, everything. This means that pharmaceutical companies are now required to create a new paradigm, with the patient at the center. An initiative that began last year withi...
By PharmaVoice Team • Aug. 1, 2015 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
In the rare disease community there is saying: Alone we are rare, together we are strong. Wendy White, senior VP, for rare diseases, at Dohmen Life Science Services, a board member of Global Genes, and the president of the Heathcare Businesswomen’s Association (HBA), shared her personal rare dis...
By Taren Grom • June 1, 2015 -
PharmaVoice Team/PharmaVoice
Pharma Trax
Uptake of Digital Records Not sufficient to Drive Better Care Trending now: Despite increased use of electronic medical records, fewer U.S. doctors believe it improves health outcomes. Most U.S. doctors are more proficient using electronic medical records (EMR) than they were two years ago, but f...
By PharmaVoice Team • June 1, 2015 -
PharmaVoice Team/PharmaVoice
Patient Engagement: Not Just For Physicians Anymore
When Pfizer wanted to engage with people living with chronic pain, it used an online crowdsourcing model and social media campaign that connected thousands of people, from patients and caregivers, to nurses and doctors. In what was the first initiative of its kind by a pharmaceutical company, Pfi...
By Robin Robinson • June 1, 2015 -
PharmaVoice Team/PharmaVoice
2015 DIA Preview
The DIA Annual Meeting brings together key thought leaders and innovators from industry, academia, government and regulatory agencies, health, patient, and philanthropic organizations from around the globe and across all disciplines involved in the discovery, development, and life-cycle managemen...
By PharmaVoice Team • June 1, 2015 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Clinical Solutions: Clinical Services Market Poised For Growth
According to a recent report from JZ Med, the global clinical trial service market is expected to reach more than $64 billion by 2020, up from $38.4 billion at present, representing a CAGR of 9% between 2015 and 2020. By 2020 the average clinical trial outsourcing penetration will likely reach ar...
By PharmaVoice Team • June 1, 2015 -
PharmaVoice Team/PharmaVoice
Patient or Partner? Building An Innovative Relationship for the Future
The healthcare industry has struggled with many changes in the last 10 years, including the inevitable patent cliff, the emergence of patient advocacy, increased regulatory and healthcare reform, and the rising cost of doing business. However, even in this age of rapid innovation and adaptability...
By Marc Sirockman • June 1, 2015 -
PharmaVoice Team/PharmaVoice
Which Patients Are Really at Risk For Becoming Non-Adherent?
If you’re targeting only the most obvious patients with your medication adherence programs, you’re missing out on a big opportunity. Quite often, outreach programs focus on individuals hovering around the 80% threshold for proportion of days covered (PDC). It makes sense. Why not use your resourc...
By Craig Schilling • June 1, 2015 -
PharmaVoice Team/PharmaVoice
Seeing the Big Picture With Visual Data Analytics
Pharmaceutical and biotechnology companies are facing a gigantic increase in data — not just in volume, but in complexity. The number of clinical trials in the National Institute of Health’s registry has jumped from 5,635 in 2000 to 183,991 in 2015 — an increase of more than 30 times. The data la...
By Greg Moody • June 1, 2015 -
PharmaVoice Team/PharmaVoice
Five Tips for Expediting Clinical Trial Recruitment and Enhancing Patient Retention
According to the National Institutes of Health (NIH), more than 80% of clinical trials in the United States fail to meet their patient recruitment timelines. These delays increase costs, deplete resources, and prolong the time to market introduction. Patient recruitment is challenging as it invol...
By Lou Shapiro • June 1, 2015 -
PharmaVoice Team/PharmaVoice
Everything You Wanted to Know About Pharmacovigilance But Have Been Afraid to Ask
From the time humans begin taking an investigational new drug, pharmacovigilance measures play a critical role in every phase of a product’s lifecycle. However, understanding pharmacovigilance requirements can be daunting even for seasoned industry pros. This overview will answer all the question...
By Veronique Basch • June 1, 2015 -
PharmaVoice Team/PharmaVoice
Early Cancer Detection
For most cancers, diagnosis happens too late, when the cancer has worsened or metastasized. But when cancers are diagnosed early, survival statistics are much higher. For example, the five-year survival rate for patients diagnosed with colorectal cancer is around 90% if diagnosed when the cancer ...
By Denise Myshko • May 1, 2015 -
PharmaVoice Team/PharmaVoice
UpFront
Industry at Large Olympic cross-country skier Kris Freeman at the ADA camp. Mr. Freeman is one of the motivational speakers Lilly Diabetes provides as part of the Lilly Camp Care Package program. Lilly Supports Camps for Children with Diabetes Lilly Diabetes is supporting the American Diabetes As...
By PharmaVoice Team • April 1, 2015 -
PharmaVoice Team/PharmaVoice
What's New
Next20 Launched as Healthcare Thought Partnership Firm Trending now: Senior pharmaceutical industry executives establish new company and business model. Three highly experienced pharmaceutical and healthcare industry executives have formed next20, a new “thought partnership," which provides strat...
By PharmaVoice Team • April 1, 2015 -
PharmaVoice Team/PharmaVoice
Tools of the Trade
PHT Provides Mobile Engagement Apps for Increased Patient Retention in Clinical Trials Trending now: Patient-focused mobile apps designed to increase patient engagement and protocol compliance can help reduce participant dropout rate. PHT is expanding its suite of patient-centric apps for improve...
By PharmaVoice Team • April 1, 2015 -
PharmaVoice Team/PharmaVoice
Innovations: Apps and Websites
App Screens for Early Vision Loss GoCheckKids Screens Children Younger than 5 Years Pediatricians now have a new way to screen for amblyopia, a leading cause of vision loss in children. Gobiquity Mobile Health’s GoCheck Kids is the first pediatric vision screener app designed to facilitate early ...
By PharmaVoice Team • April 1, 2015 -
PharmaVoice Team/PharmaVoice
Innovations: Drug Therapies
First and Only Vaccine Approved for Meningitis Pfizer’s Trumenba a Key Public Health Advance A serious and life-threatening disease can now be prevented with the first and only FDA-approved vaccine in its class. Pfizer’s Trumenba Meningococcal Group B Vaccine was granted accelerated approval by ...
By PharmaVoice Team • April 1, 2015 -
PharmaVoice Team/PharmaVoice
On the Calendar
Coming Attractions Denice Torres, president of McNeil Consumer Healthcare, a Johnson & Johnson company, has been named the Healthcare Businesswomen’s Association’s 2015 Woman of the Year (WOTY). She will be honored at the 26th Woman of the Year event at the New York Hilton Midtown on Thursday...
By PharmaVoice Team • March 1, 2015 -
PharmaVoice Team/PharmaVoice
Cancer: Understanding The Patient Journey
Industry leaders talk often about being focused on patients, developing outcomes-based solutions, providing value to patients, and developing personalized and precision medicine. But what does it mean to be patient-centric in the pharmaceutical industry? Is it patient engagement? Is it addressing...
By Denise Myshko • March 1, 2015 -
PharmaVoice Team/PharmaVoice
Re-Imagining the Future of the Life-sciences Industry
The pharmaceutical industry — after facing dramatic changes over the past 10 years or so — has more transformative changes ahead. With an increasingly restrictive physician landscape, an ever-changing payer market, and technological advances that are speeding processes and improving data collecti...
By Robin Robinson • Feb. 1, 2015 -
PharmaVoice Team/PharmaVoice
Personalized Medicine: Personalized Medicine Gains Momentum
Personalized and precision medicines have the potential to change the way we think about, identify, and manage healthcare. In the years since the completion of the Human Genome Project, advances in genome technology have led to an exponential decrease in sequencing costs. This has led to more tha...
By PharmaVoice Team • Nov. 15, 2014 -
PharmaVoice Team/PharmaVoice
Business Models: Business Model Challenges
Life-sciences companies will need to employ new business models to understand the data now available from multiple sources. In the pharmaceutical industry, data are generated from several sources, including the R&D process itself, retailers, patients, and caregivers. Effectively using these d...
By PharmaVoice Team • Nov. 15, 2014 -
PharmaVoice Team/PharmaVoice
Digital Disruption: Digital Disruption 101: It's Here
Technologies and social media are greatly transforming life-sciences across all sectors. Digital disruption is occurring all around the world, and the life-sciences industry is no exception. As technologies, telemedicine, and mHealth services gain traction, providers, health plans, and pharma com...
By PharmaVoice Team • Nov. 15, 2014
Previous
